New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For GERN;HK;HWD;ISRG;MRO;ONTY;THLD;TROX;ZIOP;STRZA;XWES;NFLX From The Last 14 Days
Check below for free stories on GERN;HK;HWD;ISRG;MRO;ONTY;THLD;TROX;ZIOP;STRZA;XWES;NFLX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | all recent news | >>
July 22, 2014
09:36 EDTNFLXActive equity options trading on open
Subscribe for More Information
09:00 EDTNFLXNetflix price target raised to $500 from $425 at Cantor
Subscribe for More Information
07:57 EDTNFLXNetflix price target raised to $550 from $500 at JPMorgan
Subscribe for More Information
07:17 EDTNFLXNetflix outlook still uncertain, says Bernstein
Subscribe for More Information
07:15 EDTZIOPZiopharm announces expansion of oncology programs with Intrexon
Ziopharm (ZIOP) announced the expansion of synthetic immuno-oncology programs in conjunction with Intrexon (XON) to include chimeric antigen receptor T-cell, or CAR-T, therapy. Additionally the company has provided an update on its development efforts with the proprietary RheoSwitch Therapeutic System, or RTS, platform, an inducible regulator for expression of therapeutic molecules through administration of an oral activator ligand, as well as its clinical program with Ad-RTS-IL-12, a novel DNA-based therapeutic candidate for the controlled expression of IL-12. CAR-T cells represent an emerging, high value immunological therapy that can target and destroy cancer cells displaying "personalized" fingerprints, yet current approaches feature challenges associated with toxicity, off-target effects, and uneconomical manufacturing. Intrexon possesses the integrated technology platforms, molecular engineering, systems biology, and cell engineering capabilities required to overcome these challenges and fully realize the potential of CAR]T cell therapies. Most significantly, utilization of the RTS platform will facilitate exquisite regulation of one or more bioeffectors in CAR-T cells enabling physicians to control systemic effects of cell therapies with an appropriate dosing regimen of the oral activator ligand, and eventually bring about improved safety and efficacy of these and related therapeutic strategies. Further preclinical work is underway in this promising area of study, and ZIOPHARM and Intrexon expect to provide a progress update in the second half of 2014.
06:49 EDTNFLXNetflix price target raised to $453 from $410 at Citigroup
Subscribe for More Information
06:31 EDTNFLXNetflix reported solid Q2 results, says Piper Jaffray
Subscribe for More Information
06:18 EDTNFLXNetflix price target raised to $350 from $300 at Jefferies
Subscribe for More Information
July 21, 2014
18:40 EDTNFLXOn The Fly: After Hours Movers
UP AFTER EARNINGS: Netflix (NFLX), up marginally after reporting Q2 results... Sanmina (SANM), up 13.2% after reporting third quarter results and fourth quarter guidance above analyst estimates... Chipotle (CMG), up 10.1%... Helix (HLX), up 5.2%... Canadian National (CNI), up 1.13%... CYS Investments (CYS), up 1.7%. ALSO HIGHER: Apache (APA), up 5% after Bloomberg says JANA discloses $1B position... Johnson & Johnson (JNJ), up 1% after announcing a $5B share repurchase program... TG Therapeutics (TGTX), up 4.3% after reporting second quarter results and preliminary clinical results from TG-1101 Phase I study... DOWN AFTER EARNINGS: Rambus (RMBS), down 3.6% after reporting second quarter results... Ultra Clean (UCTT), down 4% after reporting quarterly results. ALSO LOWER: Tallgrass Energy (TEP), down 5% after filing to sell 7M common units representing limited partners.
17:39 EDTNFLXNetflix says can achieve U.S-like margins in international business
Subscribe for More Information
17:32 EDTNFLXNetflix says very excited for 'ambitious' Marco Polo project
Subscribe for More Information
17:29 EDTNFLXNetflix sees producing original content for Europe expansion
Subscribe for More Information
17:20 EDTNFLXNetflix sees dip in Q4,Q1 free cash flow as company expands 'originals'
Subscribe for More Information
16:18 EDTNFLXNetflix says policy goal is for DOJ/FCC to block Comcast, TWC deal
Subscribe for More Information
16:07 EDTNFLXNetflix rallies 1% to $456.53 following Q2 results
Subscribe for More Information
16:07 EDTNFLXNetflix says international approaching contribution profitability
Subscribe for More Information
16:06 EDTNFLXNetflix to launch in Germany, France, others in September
Subscribe for More Information
16:05 EDTNFLXNetflix sees Q3 net additions 3.69M to 53.74M members
Subscribe for More Information
16:02 EDTNFLXNetflix reports Q2 total streaming net additions 1.69M
Netflix reports Q2 total streaming members 50.05M. The company reports international streaming net additions of 1.12M to 13.8M.
16:01 EDTNFLXNetflix sees Q3 EPS 89c, consensus $1.06
Sees Q3 revenue $1.22B, consensus $1.38B.
<< 1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use